Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome
Buntaro Fujita(Heart and Diabetes Center North Rhine-Westphalia), Sandra Landwehr(BQS Institut für Qualität und Patientensicherheit (Germany)), Helge Möllmann(Kerckhoff Klinik), Raffi Bekeredjian(Robert Bosch Hospital), Tobias Schmidt(Asklepios Klinik St. Georg), Stephan Ensminger(University of Zurich), Christian Frerker(University Hospital Schleswig-Holstein), Timm Bauer(Justus-Liebig-Universität Gießen), Thomas Walther(University Hospital Frankfurt), Hugo A. Katus(Heidelberg University), Sabine Bleiziffer(Deutsches Herzzentrum München), Friedhelm Beyersdorf, Wolfgang Harringer(Klinikum Braunschweig), Christian W. Hamm(Universitätsklinikum Gießen und Marburg), Andreas Beckmann(Klinik Niederrhein)
Cited by 74
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k